Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.63 USD | -4.00% | +44.50% | +22.58% |
14/05 | Raymond James Downgrades CareDx to Market Perform From Outperform | MT |
13/05 | Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.08% | 79Cr | |
-27.87% | 996.46Cr | |
-6.47% | 302.62Cr | |
+31.24% | 299.98Cr | |
-14.73% | 217.51Cr | |
-14.72% | 175.98Cr | |
+67.79% | 142.13Cr | |
-2.18% | 76Cr | |
+3.18% | 31Cr | |
+6.63% | 21Cr |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx : Goldman Sachs Starts CareDx at Buy With $95 Price Target